The company's lackluster revenue growth and absence of profi...
The company's lackluster revenue growth and absence of profits is concerning, despite a falling share price presenting a potential opportunity if long-term growth potential can be discerned.
Investors in Fujian Aonong Biological Technology Group Incorporation (SHSE:603363) From a Year Ago Are Still Down 38%, Even After 6.1% Gain This Past Week
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment
Moomoo AI Official Account
Your AI assistant for discovering investment opportunities.
4543Followers
0Following
9930Visitors
Follow